Trinean

Trinean

Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout

$4.7m

Early VC

€3.7m

Early VC

N/A

Acquisition
Total Funding$8.8m

Recent News about Trinean

Edit
More about Trineaninfo icon
Edit

Trinean, operating under the brand Unchained Labs, specializes in providing advanced analytical tools for the life sciences sector. The company focuses on developing instruments that aid in the quantification, stability, and characterization of proteins and nucleic acids, which are essential for biologic development. Their products serve a wide range of clients, including pharmaceutical companies, biotech firms, and academic research institutions. Trinean operates in the highly specialized market of biologic development, offering solutions that streamline and enhance the accuracy of research and development processes. The business model revolves around the sale of high-precision instruments and related services, generating revenue through direct sales, service contracts, and consumables. By addressing critical needs in protein and nucleic acid analysis, Trinean helps its clients accelerate their research and development timelines, ultimately contributing to faster and more efficient drug discovery and development.

Keywords: protein quantification, nucleic acid analysis, biologic development, pharmaceutical tools, biotech instruments, research accuracy, stability characterization, life sciences, analytical tools, drug discovery.